BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models.
Times cited: 1
Pre-clinical efficacy of PU-H71, a novel HSP90 inhibitor, alone and in combination with bortezomib in Ewing sarcoma.
Times cited: 13
- A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas. Nature Medicine. 2009 Academic Article GET IT
- Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines. Cancer research. 2008 Academic Article GET IT
Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents.
Current opinion in investigational drugs (London, England : 2000).
Times cited: 78